Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
379.118650526
InChI
InChI=1S/C19H21NO5.ClH/c1-2-5-18-16(4-1)22-12-15(25-18)11-20-8-3-9-21-14-6-7-17-19(10-14)24-13-23-17;/h1-2,4-7,10,15,20H,3,8-9,11-13H2;1H/t15-;/m0./s1
InChI Key
InChIKey=GGNCUSDIUUCNKE-RSAXXLAASA-N
IUPAC Name
[3-(2H-1,3-benzodioxol-5-yloxy)propyl][(2S)-2,3-dihydro-1,4-benzodioxin-2-ylmethyl]amine hydrochloride
Traditional IUPAC Name
[3-(2H-1,3-benzodioxol-5-yloxy)propyl][(2S)-2,3-dihydro-1,4-benzodioxin-2-ylmethyl]amine hydrochloride
SMILES
Cl.C(CNC[C@H]1COC2=CC=CC=C2O1)COC1=CC2=C(OCO2)C=C1
pKa (Strongest Basic)
9.1
Refractivity
90.59 m3·mol-1
Cơ Chế Tác Dụng :
MN-305 is a novel, potent and highly selective serotonin 5-HT1A receptor agonist under development by MediciNova for the treatment of anxiety disorders beginning with Generalized Anxiety Disorder (GAD).
MN-305 is a potent and highly-selective full agonist at the serotonin 5-HT1A receptor under development by MediciNova both for the treatment of insomnia, as well as for anxiety disorders such as Generalized Anxiety Disorder (GAD). MN-305 has been evaluated in an extensive preclinical toxicology program which showed no evidence of inducing genetic mutations, immune response or cancer. MN-305 has also proved to be consistently well-tolerated in clinical safety, efficacy and pharmacokinetic studies in over 1,200 subjects.
Chỉ Định :
Investigated for use/treatment in anxiety disorders, depression, insomnia, and neurologic disorders.